Cervical cancer is a malignant neoplasm originating from the cells of the cervix, the lower cylindrical part of the uterus that connects to the vagina. The vast majority of these cancers develop within the transformation zone, a dynamic area where the columnar epithelium of the endocervix meets the stratified squamous epithelium of the ectocervix. Persistent infection with high-risk types of the Human Papillomavirus (HPV), particularly types 16 and 18, drives cellular transformation. Viral oncoproteins E6 and E7 deactivate host tumor suppressor proteins p53 and retinoblastoma (Rb), allowing uncontrolled cellular proliferation, dysplasia, and eventually invasive carcinoma.
While high-risk HPV infection is the necessary precursor for cervical cancer, several co-factors increase the likelihood of persistent infection and malignant progression. Understanding these variables helps nurses identify vulnerable populations during community outreach.
Early-stage cervical cancer is frequently asymptomatic, which underscores the necessity of routine screening. As the lesion progresses, patients typically present with abnormal vaginal bleeding, such as intermenstrual spotting, post-coital bleeding, or menorrhagia. In advanced stages, patients may experience foul-smelling vaginal discharge, pelvic pain, lower back pain radiating down the legs, and urinary or bowel symptoms if the tumor invades adjacent pelvic organs.
Staging relies on the FIGO (International Federation of Gynecology and Obstetrics) classification system, which traditionally utilizes clinical examination, cystoscopy, proctoscopy, and basic imaging. Modern staging increasingly incorporates advanced imaging like MRI and CT scans to assess precise tumor size, stromal invasion, and lymph node metastasis.
Secondary prevention relies on identifying precancerous lesions before they transform into invasive carcinoma.
Treatment modalities depend heavily on the clinical stage of the disease, patient age, and overall health status. Early-stage lesions (Stage IA to IB1) are frequently managed with fertility-sparing procedures like cone biopsy or radical trachelectomy, or definitive radical hysterectomy with pelvic lymph node dissection. Advanced stages require concurrent chemoradiotherapy, combining external beam radiation therapy (EBRT) with platinum-based chemotherapy (such as cisplatin), followed by brachytherapy to deliver localized radiation directly to the tumor site. Palliative care approaches are integrated when the disease is recurrent or metastatic.
Comprehensive nursing management addresses the physical, psychological, and emotional needs of women undergoing treatment for cervical cancer. Nurses monitor for post-operative complications such as hemorrhage, infection, and urinary retention following radical pelvic surgeries. For patients receiving radiation, nurses manage side effects like radiation cystitis, proctitis, and severe fatigue. Psychological support is paramount, as a gynecological cancer diagnosis often impacts body image, sexual health, and fertility. Nurses provide empathetic counseling, connect patients with support groups, and coordinate multidisciplinary palliative care referrals when necessary.
Cervical cancer remains a leading cause of cancer mortality among Nigerian women, largely due to resource constraints and low screening coverage. Public health initiatives focus on primary prevention through HPV vaccination programs targeted at young adolescent girls before sexual debut. Secondary prevention centers on scaling up low-cost screening methods such as Visual Inspection with Acetic Acid (VIA) combined with immediate treatment using thermal ablation ('see-and-treat' approach) in rural healthcare settings. Overcoming cultural barriers, addressing financial constraints, and integrating education into primary healthcare structures are vital components of national control plans.